B
Novo Nordisk A/S NVO
$128.47 $3.212.56%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2023 09/30/2023 06/30/2023 03/31/2023 12/31/2022
Net Income 3.17B 3.28B 2.84B 2.85B 1.87B
Total Depreciation and Amortization 94.56M 368.75M 318.08M 247.68M 141.62M
Total Amortization of Deferred Charges 30.75M -- -- -- 26.79M
Total Other Non-Cash Items -519.28M 627.10M 1.61B 2.67B -1.02B
Change in Net Operating Assets -1.40B 1.70B -586.64M -1.47B -42.31M
Cash from Operations 1.38B 5.98B 4.18B 4.30B 975.39M
Capital Expenditure -1.36B -851.12M -858.84M -676.19M -681.44M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- -971.82M
Divestitures -- -- -- -- --
Other Investing Activities -766.57M -1.08B -497.80M -281.54M -249.17M
Cash from Investing -2.12B -1.93B -1.36B -957.73M -1.90B
Total Debt Issued -- -- -- -- 95.00M
Total Debt Repaid -355.00M -261.00M -373.00M -478.00M -224.00M
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -9.76B -6.14B -8.82B -5.20B -7.54B
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid 0.00 -1.96B 0.00 -2.64B 0.00
Other Financing Activities -- -- -3.39B 3.39B --
Cash from Financing -1.46B -2.90B -1.84B -2.97B -1.05B
Foreign Exchange rate Adjustments -30.17M 61.04M -9.50M -37.89M -115.93M
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -2.24B 1.21B 969.89M 328.94M -2.10B
Weiss Ratings